<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJPed</journal-id><journal-title-group><journal-title>Open Journal of Pediatrics</journal-title></journal-title-group><issn pub-type="epub">2160-8741</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojped.2024.141004</article-id><article-id pub-id-type="publisher-id">OJPed-130387</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Clinical and Bacteriological Profile of Infections in Sickle Cell Children in Two Referral Hospitals in Niamey, Niger
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kamaye</surname><given-names>Moumouni</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Samaila</surname><given-names>Aboubacar</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Garba</surname><given-names>Moumouni</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Georges</surname><given-names>Thomas Ibrahim</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamoudou</surname><given-names>Abdou Djafar</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamane</surname><given-names>Halima</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hamadou</surname><given-names>Ibrahim</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hamani</surname><given-names>Issaka</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Djibrilla</surname><given-names>Almoustapha Amadou</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yacouba</surname><given-names>Abdourahamane</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Marou</surname><given-names>Soumana Boubacar</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Moussa</surname><given-names>Saley Sahada</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bade</surname><given-names>Malam Abdou</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Soumana</surname><given-names>Alido</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff5"><addr-line>Service de Biologie Médicale, H&amp;amp;#244;pital national Amirou Boubacar Diallo, Niamey, Niger</addr-line></aff><aff id="aff4"><addr-line>Service d’Onco-Hématologie, H&amp;amp;#244;pital national de Niamey, Niamey, Niger</addr-line></aff><aff id="aff1"><addr-line>Service de Pédiatrie A, H&amp;amp;#244;pital National de Niamey, Niamey, Niger</addr-line></aff><aff id="aff3"><addr-line>Service de Pédiatrie, H&amp;amp;#244;pital national Amirou Boubacar Diallo, Niamey, Niger</addr-line></aff><aff id="aff2"><addr-line>Faculté des Sciences de la Santé, Université Abdou Moumouni de Niamey, Niamey, Niger</addr-line></aff><pub-date pub-type="epub"><day>04</day><month>01</month><year>2024</year></pub-date><volume>14</volume><issue>01</issue><fpage>36</fpage><lpage>42</lpage><history><date date-type="received"><day>10,</day>	<month>September</month>	<year>2023</year></date><date date-type="rev-recd"><day>6,</day>	<month>January</month>	<year>2024</year>	</date><date date-type="accepted"><day>9,</day>	<month>January</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction:
   Infections are significant causes of mortality in sickle cell ch
  ildren in resource-limited countries. This study aimed to determine the clinical profile and bacterial ecology of infections in children with sickle-cell disease in two referral hospitals in Niamey. <b>Patients and methods: </b>A retrospective descriptive study was conducted from January 2018 to July 2020 in two referral hospitals in Niamey. All children aged one (1) to 15 years with sickle cell disease admitted for suspected infection, including at least one bacterial culture, were studied. Bacteriological analysis was performed using the appropriate culture media, using BactAlert (Reference 4700003 BTA3D60 BioM&#233;rieux). <b>Results: </b>Over 36-months, 350 children with a mean age of 10.9 months were admitted. The sex ratio was 1.2. The SS electrophoretic profile was the most common (93.4%). Immunization status was up to date in 66% of patients. Fever was the common reason for consultation (55.1%). Infection was confirmed in 62 patients (17.7%). The primary diagnoses were bacterial gastroenteritis (24.2%) and urinary tract infection (19.4%). Blood cultures were isolated from Salmonella typhi (13.0%) and Escherichia coli (8.7%). Klebsiella spp (7.1%) and Escherichia coli (5.0%)
   
  were detected 
  in 
  cytobacteriological examination of urine. Salmonella typhi (23.5%) and Escherichia coli (5.9%) were isolated on coproculture. <b>Conclusion: </b>Bacterial ecology appears not different from that usually observed in sickle-cell children. Salmonella and Escherichia coli were predominant.
 
</p></abstract><kwd-group><kwd>Sickle Cell Disease</kwd><kwd> Child</kwd><kwd> Infection</kwd><kwd> Niger</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Sickle cell disease is a cosmopolitan genetic disorder [<xref ref-type="bibr" rid="scirp.130387-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.130387-ref2">2</xref>] . In Africa, 500,000 children are born with the disease, and 60% to 80% die before age of five years due to a lack of early detection and adequate treatment [<xref ref-type="bibr" rid="scirp.130387-ref3">3</xref>] . Infections frequently punctuate the course of the disease, and are life-threatening for children, especially in resource-limited countries [<xref ref-type="bibr" rid="scirp.130387-ref1">1</xref>] . Their highest incidence is observed in the first years of life, and their frequency decreases with age, but the risk persists throughout life. Meningitis and septicemia are the most serious infections in children [<xref ref-type="bibr" rid="scirp.130387-ref3">3</xref>] . A better understanding of the mapping of infections encountered should enable us to improve management and envisage more appropriate preventive measures. This study aimed to determine the clinical profile and the ecology of bacteria found in infections among sickle-cell children admitted to two referral hospitals in Niamey.</p></sec><sec id="s2"><title>2. Patients and Methods</title><sec id="s2_1"><title>2.1. Type, Period and Study Setting</title><p>A retrospective descriptive study was conducted from January 2018 to July 2020 (36 months) in the pediatric wards of Niamey National Hospital and Amirou Boubacar Diallo National Hospital, two referral hospitals in Niamey.</p></sec><sec id="s2_2"><title>2.2. Study Population and Variables</title><p>All sickle-cell children (SS or SC electrophoretic profile) aged between one (1) to 15 years admitted to the corresponding departments for suspicion of bacterial infection were included. All usable records containing at least one bacterial culture (urine, stool or blood) were studied. Children’s socio-demographic characteristics, clinical signs and culture results were the studied variables.</p></sec><sec id="s2_3"><title>2.3. Sampling Technique and Analysis Methods</title><p>Urine was collected per micturition on the first micturition in a sterile jar in the morning. Stools were also collected aseptically in a sterile jar fitted with a sampling spatula. Blood cultures were taken in the event of a febrile peak (≥38.5˚C) or hypothermia (≤36.5˚C) in culture media. All samples were taken in hospital, and then transported to the laboratory in no more than one hour for processing. Lumbar puncture was performed if patients had neurological signs. Bacteriological analysis was carried out using the appropriate culture media, using BactAlert (Reference 4700003 BTA3D60 BioM&#233;rieux).</p></sec><sec id="s2_4"><title>2.4. Data Collection, Source and Statistical Analysis</title><p>A data extraction sheet was used to collect information from patients’ hospitalization records, and from the biology laboratory’s registers. Data were entered and analyzed using Epi-Info7 version 7.2.1 software. Results were expressed as numbers and percentages for children’s variables and bacteriological data.</p></sec><sec id="s2_5"><title>2.5. Ethical Aspects</title><p>The study was approved by the Faculty of Health Sciences of Abdou Moumouni University of Niamey, and the management of both hospitals. Anonymity and medical confidentiality were respected.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Characteristics of Children</title><p>Over 36 months, 350 children with sickle cell disease were admitted for suspected bacterial infection. <xref ref-type="table" rid="table1">Table 1</xref> shows Children characteristics. The mean age was 10.9 months [6 months-14 years]. The sex ratio was 1.2. The SS electrophoretic profile was the most common (93.4%). Classical Expanded Program of Immunization (EPI) vaccination status (diphtheria, tetanus, pertussis, poliomyelitis, yellow fever, measles and pneumococcus) was up to date in 66% of patients. None had received vaccines outside the EPI. Fever was the most frequent reason for consultation (55.1%), followed by pallor (52.1%). C-reactive protein (more than 6 mg.L<sup>−1</sup> was positive in 84.4% of cases, and hyperleukocytosis, defined as a white blood cell count above 20.000 cells/&#181;L, was found in 96.4%. The diagnosis of infection was confirmed in 62 patients (17.7%). The most frequent diagnoses (<xref ref-type="table" rid="table2">Table 2</xref>) were bacterial gastroenteritis (24.2%), urinary tract infection (19.4%), pneumonia (19.4%) and acute osteomyelitis (9.7%).</p></sec><sec id="s3_2"><title>3.2. Bacteriological Profile</title><p>Bacteriological results are shown in <xref ref-type="table" rid="table3">Table 3</xref>. Blood cultures were taken from 46 children, with 28.3% of positivity. The main germs isolated were Salmonella typhi (13.0%) and Escherichia coli (8.7%). Urine cytobacteriological examination (UCBE) was carried out in 99 patients, with 12.1% of positive results. Klebsiella spp (7.1%) and Escherichia coli (5.0%) were found. Fifty-one (51) coprocultures were requested, with 29.4% positive results. Salmonella typhi (23.5%) and Escherichia coli (5.9%) were isolated. Cytobacteriological examination of cerebrospinal fluid revealed one (1) case of Streptococcus pneumoniae. Ceftriaxone combined with gentamicin was used in 96.3% in the treatment. Progression was favorable in the majority of patients (99.4%). One (1) death resulting from complications of anemia was observed.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>Management of bacterial infections in sickle cell children should be based on probabilistic antibiotic therapy, considering to avoid progression to severe sepsis [<xref ref-type="bibr" rid="scirp.130387-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.130387-ref2">2</xref>] . Based on the observations of this study, the bacterial ecology in our context was similar to that usually reported in the literature. The limitations of this work were mainly related to the almost systematic prescription of antibiotics in hospitalized sickle cell patients, which probably increased the low culture positivity rate. In all cases, the incidence and severity of infections, and the context of limited resources, justify this therapeutic attitude.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Characteristics of children</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Effective</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle"  colspan="3"  >Sex</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >165</td><td align="center" valign="middle" >47.1</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >135</td><td align="center" valign="middle" >52.9</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Age range</td></tr><tr><td align="center" valign="middle" >6 - 11</td><td align="center" valign="middle" >91</td><td align="center" valign="middle" >26</td></tr><tr><td align="center" valign="middle" >12 - 59</td><td align="center" valign="middle" >170</td><td align="center" valign="middle" >48.6</td></tr><tr><td align="center" valign="middle" >60</td><td align="center" valign="middle" >89</td><td align="center" valign="middle" >25.4</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Electrophoretic profile</td></tr><tr><td align="center" valign="middle" >SS</td><td align="center" valign="middle" >327</td><td align="center" valign="middle" >93.4</td></tr><tr><td align="center" valign="middle" >SC</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >6.6</td></tr><tr><td align="center" valign="middle"  colspan="3"  >EPI* status</td></tr><tr><td align="center" valign="middle" >Up to date</td><td align="center" valign="middle" >231</td><td align="center" valign="middle" >66</td></tr><tr><td align="center" valign="middle" >Not up to date</td><td align="center" valign="middle" >119</td><td align="center" valign="middle" >34</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Clinical signs</td></tr><tr><td align="center" valign="middle" >Fever</td><td align="center" valign="middle" >194</td><td align="center" valign="middle" >55.1</td></tr><tr><td align="center" valign="middle" >Mucocutaneous pallor</td><td align="center" valign="middle" >193</td><td align="center" valign="middle" >52.1</td></tr><tr><td align="center" valign="middle" >Osteoarticular pain</td><td align="center" valign="middle" >129</td><td align="center" valign="middle" >36.8</td></tr><tr><td align="center" valign="middle" >Diarrhea/Vomiting</td><td align="center" valign="middle" >53</td><td align="center" valign="middle" >15.1</td></tr><tr><td align="center" valign="middle" >Abdominal pain</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >14.2</td></tr><tr><td align="center" valign="middle" >Cough</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >12.9</td></tr><tr><td align="center" valign="middle" >Hand-foot syndrome</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >8.4</td></tr><tr><td align="center" valign="middle" >Respiratory distress</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >Other</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >4</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Diagnoses</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Diagnose</th><th align="center" valign="middle" >Effective</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle" >Bacterial gastroenteritis</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >24.2</td></tr><tr><td align="center" valign="middle" >Pneumonia</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >19.4</td></tr><tr><td align="center" valign="middle" >Urinary tract infection</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >19.4</td></tr><tr><td align="center" valign="middle" >Acute osteomyelitis</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >9.7</td></tr><tr><td align="center" valign="middle" >Septicemia</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >9.7</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >17.6</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Isolated germs</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Type of culture/Germ</th><th align="center" valign="middle" >Effective</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle"  colspan="3"  >Blood culture</td></tr><tr><td align="center" valign="middle" >Salmonella typhi</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >13.0</td></tr><tr><td align="center" valign="middle" >Escherichia coli</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >8.7</td></tr><tr><td align="center" valign="middle" >Staphylococcus aureus</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >6.5</td></tr><tr><td align="center" valign="middle" >Sterile</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >71.8</td></tr><tr><td align="center" valign="middle"  colspan="3"  >UCBE*</td></tr><tr><td align="center" valign="middle" >Klebsiella spp</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >7.1</td></tr><tr><td align="center" valign="middle" >Escherichia coli</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >5.0</td></tr><tr><td align="center" valign="middle" >Sterile</td><td align="center" valign="middle" >87</td><td align="center" valign="middle" >87.9</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Coproculture</td></tr><tr><td align="center" valign="middle" >Salmonella typhi</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >23.5</td></tr><tr><td align="center" valign="middle" >Escherichia coli</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >5.9</td></tr><tr><td align="center" valign="middle" >Sterile</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >70.6</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Cerebro-Spinal Fluid culture</td></tr><tr><td align="center" valign="middle" >Streptococcus pneumoniae</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >Sterile</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >90</td></tr></tbody></table></table-wrap><p>*UCBE: Urine cytobacteriological examination.</p><sec id="s4_1"><title>4.1. Characteristics of Children</title><p>The predominance of children under five years of age in this series has been reported by Diakit&#233; et al. [<xref ref-type="bibr" rid="scirp.130387-ref4">4</xref>] in Mali and Latoundji et al. [<xref ref-type="bibr" rid="scirp.130387-ref5">5</xref>] in Benin. Generally, the high susceptibility of sickle-cell patients to infection is well known, and the risk of infection is greatest in younger children, particularly infants [<xref ref-type="bibr" rid="scirp.130387-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.130387-ref2">2</xref>] . In addition to the physiological immaturity of the immune system in this age group, functional asplenia associated with abnormalities in immunoglobulins, leukocyte function and cell-mediated immunity could further weaken the means of infectious control in these children [<xref ref-type="bibr" rid="scirp.130387-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.130387-ref7">7</xref>] .</p></sec><sec id="s4_2"><title>4.2. Bacteriology</title><p>Knowledge of the local bacterial ecology is essential for effective antibiotic prophylaxis and vaccination prevention programs. In this study, Salmonella typhi and Escherichia coli dominated the bacteriological profile. In the series by Douamba et al. in Burkina Faso, Streptococcus pneumoniae (35.5%) and Salmonella spp (33.3%) were more frequently reported [<xref ref-type="bibr" rid="scirp.130387-ref8">8</xref>] . The predominance of Streptococcus pneumoniae found by these authors can be explained by the fact that brocho-pneumonia being the most frequent diagnosis. Indeed, pneumonia in children with sickle cell disease is essentially due to Streptococcus pneumoniae [<xref ref-type="bibr" rid="scirp.130387-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.130387-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.130387-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.130387-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.130387-ref12">12</xref>] . The relatively high EPI vaccination coverage in our context, considers this bacterium, and the systematic antibiotic prophylaxis with oral penicillin in all sickle-cell children, could explain the low proportion of pneumococcal infections observed. Generally, invasive pneumococcal infections have been a major cause of morbidity and mortality in sickle cell patients, especially in precarious living conditions. These infections are often brutal and severe, making curative treatments often ineffective [<xref ref-type="bibr" rid="scirp.130387-ref13">13</xref>] . While preventive antibiotic therapy with penicillotherapy has proved effective, vaccination remains the principal means of control [<xref ref-type="bibr" rid="scirp.130387-ref14">14</xref>] . Salmonella typhi, found in coprocultures in this study, is more likely to be implicated in osteoarticular infections [<xref ref-type="bibr" rid="scirp.130387-ref15">15</xref>] . According to the authors, this could be explained by their high susceptibility to osteoarticular infections. What’s more, these infections are endemic in the context of poor living conditions [<xref ref-type="bibr" rid="scirp.130387-ref3">3</xref>] . However, effective prevention through vaccination has been available for many years. This should be offered systematically to all children with a tare, generally from the age of two for the polysaccharide vaccine, and six months for the conjugate vaccine [<xref ref-type="bibr" rid="scirp.130387-ref16">16</xref>] . Other studies have also reported the predominance of Escherichia coli and Klebsiella spp in urinary tract infections. The perineum is highly colonized by enterobacteria of digestive origin, in particular Escherichia coli. In addition, this bacterium possesses specific uropathogenicity factors, thus favoring these infections [<xref ref-type="bibr" rid="scirp.130387-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.130387-ref18">18</xref>] .</p></sec></sec><sec id="s5"><title>5. Conclusion</title><p>Bacterial ecology appears not different from that usually observed in sickle-cell children. Salmonella typhi and Escherichia coli predominate, mainly responsible for urinary tract and gastrointestinal infections. Prophylaxis must therefore take these results into account, particularly about Salmonella. Indeed, an immunization program should be set up for sickle cell children. It would also be necessary to strengthen diagnostic resources to enable a more complete mapping of pathogens, and to adapt preventive measures.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Moumouni, K., Aboubacar, S., Moumouni, G., Ibrahim, G.T., Djafar, M.A., Halima, M., Ibrahim, H., Issaka, H., Amadou, D.A., Abdourahamane, Y., Boubacar, M.S., Sahada, M.S., Abdou, B.M. and Alido, S. (2024) Clinical and Bacteriological Profile of Infections in Sickle Cell Children in Two Referral Hospitals in Niamey, Niger. Open Journal of Pediatrics, 14, 36-42. https://doi.org/10.4236/ojped.2024.141004</p></sec></body><back><ref-list><title>References</title><ref id="scirp.130387-ref1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Choudja</surname><given-names> C.J. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>Les enfants avec une drépanocytose—Un mémento pour le pédiatre</article-title><source> Paediatrica</source><volume> 23</volume>,<fpage> 16</fpage>-<lpage>19</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.130387-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Girot, R. and Bégué, P. (2004) Sickle Cell Disease in Childhood in 2004. Bulletin de l'Académie Nationale de Médecine, 188, 491-505.  
https://doi.org/10.1016/S0001-4079(19)33778-1</mixed-citation></ref><ref id="scirp.130387-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Diallo, D.A. (2008) La drépanocytose en Afrique: Problématique, stratégies pour une amélioration de la survie et de la qualité de vie de la drépanocytose. Bulletin de l'Académie Nationale de Médecine, 192, 1361-1373.  
https://doi.org/10.1016/S0001-4079(19)32686-X</mixed-citation></ref><ref id="scirp.130387-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Diakité, A., Dembélé, A., Cissé, M., Kanté, M., Coulibaly, Y. and Ma&amp;#239;ga, B. (2019) Complications Ostéoarticulaires de la Drépanocytose au Département de Pédiatrie du CHU Gabriel Touré. Health Sciences and Disease, 20, 76-81.</mixed-citation></ref><ref id="scirp.130387-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Latoundji, S., Anani, L., Ablet, E. and Zohoun, I. (1991) Morbidité et mortalité drépanocytaire au Bénin. Médecine d'Afrique Noire, 38, 571-576.</mixed-citation></ref><ref id="scirp.130387-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Lepage, P.H., Dresse, M.F., Forget, P., Schmitz, V. and Hoyoux, C. (2004) Infections et Prophylaxies Antiinfectieuses dans la Drépanocytose. Revue Médicale de Liège, 59, 145-148.</mixed-citation></ref><ref id="scirp.130387-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Ballas, S.K. (2018) Sickle Cell Disease: Classification of Clinical Complications and Approaches to Preventive and Therapeutic Management. Clinical Hemorheology and Microcirculation, 68, 105-128. https://doi.org/10.3233/CH-189002</mixed-citation></ref><ref id="scirp.130387-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Douamba, S., Nagalo, K., Tamini, L., Traoré, I., Kam, M., Kouéta, F. and Yé, D. (2017) Syndromes drépanocytaires majeurs et infections associées chez l’enfant au Burkina Faso. Pan African Medical Journal, 26, Article 7.  
https://doi.org/10.11604/pamj.2017.26.7.9971</mixed-citation></ref><ref id="scirp.130387-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Battersby, A.J., Knox-Macaulay, H.H. and Carrol, E.D. (2010) Susceptibility to Invasive Bacterial Infections in Children with Sickle Cell Disease. Pediatric Blood &amp; Cancer, 55, 401-406. https://doi.org/10.1002/pbc.22461</mixed-citation></ref><ref id="scirp.130387-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Booth, C., Inusa, B. and Obaro, S.K. (2010) Infection in Sickle Cell Disease: A Review. International Journal of Infectious Diseases, 14, e2-e12.  
https://doi.org/10.1016/j.ijid.2009.03.010</mixed-citation></ref><ref id="scirp.130387-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Millet, A., Hullo, E., Armari Alla, C., Bost-Brua, C., Durand, C., Nugues, F., et al. (2012) Drépanocytose et salmonelloses invasives osteo-articulaires. Archives de Pédiatrie, 19, 267-270. https://doi.org/10.1016/j.arcped.2011.12.012</mixed-citation></ref><ref id="scirp.130387-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Hernigou, P., Daltro, G., Batista Sobrinho, U. and Sberge, F. (2010) Manifestations ostéoarticulaires de la drépanocytose. Gazeta Médica da Bahia, 80, 74-79.</mixed-citation></ref><ref id="scirp.130387-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Narang, S., Fernandez, I.D., Chin, N., Lerner, N. and Weinberg, G.A. (2012) Bacteremia in Children with Sickle Hemoglobinopathies. Journal of Pediatric Hematology, 34, 13-16. https://doi.org/10.1097/MPH.0b013e318240d50d</mixed-citation></ref><ref id="scirp.130387-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Adamkiewicz, T.V., Sarnaik, S., Buchanan, G.R., Iyer, R.V., Miller, S.T., Pegelow, C.H., et al. (2003) Invasive Pneumococcal Infections in Children with Sickle Cell Disease in the Era of Penicillin Prophylaxis, Antibiotic Resistance, and 23-Valent Pneumococcal Polysaccharide Vaccination. The Journal of Pediatrics, 143, 438-444.  
https://doi.org/10.1067/S0022-3476(03)00331-7</mixed-citation></ref><ref id="scirp.130387-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Banza, M.I., Kapessa, N.D., Mukakala, A.K., Ngoie, C.N., Ben N′Dwala, Y.T., Kaoma Cabala, V.D.P., et al. (2021) Les infections ostéo-articulaires chez les drépanocytaires à Lubumbashi: étude épidémiologique, étiologie et prise en charge. Pan African Medical Journal, 38, Article 77.  
https://doi.org/10.11604/pamj.2021.38.77.21484</mixed-citation></ref><ref id="scirp.130387-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Organisation Mondiale de la Santé (2008) Normes de surveillance des maladies évitables par la vaccination. Fièvre typho&amp;#239;de et autres salmonelloses invasives. OMS, Genève.</mixed-citation></ref><ref id="scirp.130387-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Mava, Y., Ambe, J.P., Bello, M., Watila, I. and Nottidge, V.A. (2011) Urinary Tract Infection in Febrile Children with Sickle Cell Anaemia. West African Journal of Medicine, 30, 268-272.</mixed-citation></ref><ref id="scirp.130387-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Ulett, G.C., Totsika, M., Schaale, K., Carey, A.J., Sweet, M.J. and Schembri, M.A. (2013) Uropathogenic Escherichia coli Virulence and Innate Immune Responses during Urinary Tract Infection. Current Opinion in Microbiology, 16, 100-107.  
https://doi.org/10.1016/j.mib.2013.01.005</mixed-citation></ref></ref-list></back></article>